---
title: "Bio International Convention – San Diego"
id: "1826"
type: "post"
slug: "bio-international-convention-san-diego"
published_at: "2026-04-20T11:58:05+00:00"
modified_at: "2026-05-26T10:58:33+00:00"
url: "https://innocorepharma.com/news-events/bio-international-convention-san-diego/"
markdown_url: "https://innocorepharma.com/news-events/bio-international-convention-san-diego.md"
taxonomy_category:
  - "Science Publications"
---

San Diego, 22 - 25 June 2026

# Bio International Convention – San Diego

# **InnoCore Pharmaceuticals at BIO International Convention 2026**

InnoCore Pharmaceuticals is proud to announce its participation in the BIO International Convention 2026, the world’s largest and most influential global biotech gathering, taking place June 22–25, 2026, at the San Diego Convention Center in San Diego, California.  
 With more than 20,000 industry leaders expected to attend, BIO 2026 offers an unparalleled platform for forging scientific partnerships, exploring emerging trends, and accelerating the next generation of biotechnology innovations.

## **Where Global Biotech Leaders Unite**

The BIO International Convention brings together the full ecosystem of biotechnology—including pharma and biotech startups—to share breakthroughs and shape the future of healthcare and life sciences. The 2026 program features four days of programming, networking, exhibitions, and insights spanning next‑generation biotherapeutics, sustained drug release and much more.

## **Meet Us in San Diego**

We invite BIO 2026 participants to connect with us, whether you’re interested in reducing the injection frequency of your drug or if you’re scouting technologies that enhance therapeutic impact, [Martin](https://innocorepharma.com/company/people/martin-bakker/)
 and [Hans](https://innocorepharma.com/company/people/hans-de-backer/)
 look forward to connecting.

"*" indicates required fields

Related insights

[26 July 2018 | Funding InnoCore and Merck enter global collaboration Merck and InnoCore Pharmaceuticals to Improve Patient Compliance with New Drug Delivery Technology. Read the full story](https://innocorepharma.com/news-events/innocore-and-merck-enter-global-collaboration/)
[11 September 2020 | Funding Bill & Melinda Gates Foundation Grant Awarded InnoCore Pharmaceuticals has been awarded a grant by the Bill & Melinda Gates Foundation to develop a long-acting injectable contraceptive implant. Read the full story](https://innocorepharma.com/news-events/innocore-awarded-grant-by-the-bill-melinda-gates-foundation-in-contraception/)
[01 January 2021 | Funding InnoCore leads Consortium in Influenza vaccines InnoCore Pharmaceuticals has secured funding from the European Regional Development Fund to develop a biodegradable polymer-based microneedle array patch. Read the full story](https://innocorepharma.com/news-events/innocore-leads-consortium-in-influenza-vaccines/)